ID

22868

Description

Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00672204

Link

https://clinicaltrials.gov/show/NCT00672204

Keywords

Versions (1)
  1. 6/13/17 6/13/17 -
Uploaded on

June 13, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Type 1 Diabetes Mellitus NCT00672204

English

Eligibility Type 1 Diabetes Mellitus NCT00672204

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. primary islet allotransplant
Description

primary islet allotransplant

Data type

boolean

Alias
UMLS CUI [1,1]
C0205225
UMLS CUI [1,2]
C1515895
UMLS CUI [1,3]
C0079646
2. type i diabetes mellitus for a minimum of 5 years
Description

type i diabetes mellitus, duration

Data type

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0449238
3. one of the following signs or symptoms despite intensive efforts made in close cooperation with their diabetic care team:
Description

signs or symptoms, diabetic care

Data type

boolean

Alias
UMLS CUI [1,1]
C3540840
UMLS CUI [1,2]
C1272423
metabolic lability/instability characterized by hypoglycemia or ketoacidosis (>2 hospital admissions in the previous year), erratic glucose profiles (mage>120 mg/dl), or disruption in lifestyle of danger to life, self or others
Description

hypoglycemia, ketoacidosis, hospital admissions, erratic glucose profiles, disruption in lifestyle of danger to life, self or others

Data type

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0220982
UMLS CUI [1,3]
C0184666
UMLS CUI [2]
C0428548
UMLS CUI [3,1]
C0023676
UMLS CUI [3,2]
C2826244
reduced awareness of hypoglycemia or >1 episode in the last 1.5 years of severe hypoglycemia
Description

reduced awareness of hypoglycemia, episode of severe hypoglycemia

Data type

boolean

Alias
UMLS CUI [1,1]
C0392756
UMLS CUI [1,2]
C1389777
UMLS CUI [1,3]
C0020615
UMLS CUI [2]
C4013228
persistently poor glucose control (as defined by hgba1c>10% at the end of six months of intensive management efforts with the diabetes care team)
Description

poor glucose control, hba1c

Data type

boolean

Alias
UMLS CUI [1,1]
C0421258
UMLS CUI [1,2]
C0202054
progressive secondary complications as defined by (i) a new diagnosis by an ophthalmologist of proliferative retinopathy or clinically significant macular edema or therapy with photocoagulation during the last year; or (ii) urinary albumin excretion rate >300 mg/day but proteinuria <3g/day; or (iii) symptomatic autonomic neuropathy (as defined by postural hypotension in the setting of euvolemia, gastroparesis or diarrhea attributed to diabetic neuropathy, or neuropathic bladder as diagnosed by an urologist)
Description

secondary complications, proliferative retinopathy or clinically significant macular edema or therapy with photocoagulation, urinary albumin excretion rate, proteinuria, symptomatic autonomic neuropathy, postural hypotension, astroparesis or diarrhea attributed to diabetic neuropathy, or neuropathic bladder

Data type

boolean

Alias
UMLS CUI [1]
C0342257
UMLS CUI [2,1]
C0339467
UMLS CUI [2,2]
C0730284
UMLS CUI [2,3]
C0395565
UMLS CUI [3,1]
C1318429
UMLS CUI [3,2]
C0033687
UMLS CUI [4,1]
C0271686
UMLS CUI [4,2]
C2676407
UMLS CUI [4,3]
C0267176
UMLS CUI [4,4]
C0342288
UMLS CUI [4,5]
C0005697
4. age 18 to 65 years of age.
Description

age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. current use of immunosuppressive agents
Description

immunosuppressive agents

Data type

boolean

Alias
UMLS CUI [1]
C0021081
2. lymphopenia (<1000/µl) or leukopenia (<3000 total leukocytes/µl)
Description

lymphopenia or leukopenia

Data type

boolean

Alias
UMLS CUI [1]
C0024312
UMLS CUI [2]
C0023530
3. presence of panel-reactive anti-hla antibody >20%
Description

panel-reactive anti-hla antibody

Data type

boolean

Alias
UMLS CUI [1]
C3508207
4. positive lymphocytotoxic cross-match using donor lymphocytes and serum
Description

lymphocytotoxic cross-match

Data type

boolean

Alias
UMLS CUI [1]
C0549171
5. evidence of acute ebv infection (igm>igg) or negative screen for ebv by igg determination
Description

ebv infection, ebv serology

Data type

boolean

Alias
UMLS CUI [1,1]
C0149678
UMLS CUI [1,2]
C0201373
6. calculated or measured gfr < 60 ml/min/m2
Description

gfr

Data type

boolean

Alias
UMLS CUI [1]
C0017654
7. portal hypertension or history of significant liver disease
Description

portal hypertension, liver disease

Data type

boolean

Alias
UMLS CUI [1]
C0020541
UMLS CUI [2]
C0023895
8. history of malignancy within 10 years (except for adequately treated basal or squamous cell ca of the skin)
Description

history of malignancy except for adequately treated basal or squamous cell ca of the skin

Data type

boolean

Alias
UMLS CUI [1]
C2735088
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
9. active peptic ulcer disease
Description

active peptic ulcer disease

Data type

boolean

Alias
UMLS CUI [1,1]
C0030920
UMLS CUI [1,2]
C2707252
10. severe unremitting diarrhea or other gi disorders potentially interfering with the ability to absorb oral medications
Description

severe diarrhea, gi disorders potentially interfering with the ability to absorb oral medications

Data type

boolean

Alias
UMLS CUI [1]
C1443924
UMLS CUI [2,1]
C0017178
UMLS CUI [2,2]
C0392687
11. untreated proliferative retinopathy
Description

untreated proliferative retinopathy

Data type

boolean

Alias
UMLS CUI [1,1]
C0339467
UMLS CUI [1,2]
C0332155
12. pregnancy or breastfeeding
Description

pregnancy or breastfeeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
13. female subjects not post-menopausal or surgically sterile, or not using an acceptable method of contraception
Description

female subjects not post-menopausal or surgically sterile, or not using an acceptable method of contraception

Data type

boolean

Alias
UMLS CUI [1,1]
C1960468
UMLS CUI [1,2]
C0015787
UMLS CUI [1,3]
C0232970
UMLS CUI [1,4]
C0700589
14. active infections
Description

active infections

Data type

boolean

Alias
UMLS CUI [1,1]
C0205177
UMLS CUI [1,2]
C3714514
15. serologic evidence of infection with hiv, or hbsag or hcv ab positive
Description

hiv, hep b, hep c

Data type

boolean

Alias
UMLS CUI [1]
C0019682
UMLS CUI [2]
C0019163
UMLS CUI [3]
C0019196
16. major ongoing psychiatric illness
Description

psychiatric illness

Data type

boolean

Alias
UMLS CUI [1]
C0004936
17. ongoing substance abuse, drug or alcohol; or recent history of noncompliance
Description

substance use disorder, compliance

Data type

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C1321605
18. any condition that in the opinion of the principle investigator would not allow for safe participation in the study
Description

comorbidity, exclusion

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2828389
Back to the top of the page

Similar models

Eligibility Type 1 Diabetes Mellitus NCT00672204

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
primary islet allotransplant
Item
1. primary islet allotransplant
boolean
C0205225 (UMLS CUI [1,1])
C1515895 (UMLS CUI [1,2])
C0079646 (UMLS CUI [1,3])
type i diabetes mellitus, duration
Item
2. type i diabetes mellitus for a minimum of 5 years
boolean
C0011854 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
signs or symptoms, diabetic care
Item
3. one of the following signs or symptoms despite intensive efforts made in close cooperation with their diabetic care team:
boolean
C3540840 (UMLS CUI [1,1])
C1272423 (UMLS CUI [1,2])
hypoglycemia, ketoacidosis, hospital admissions, erratic glucose profiles, disruption in lifestyle of danger to life, self or others
Item
metabolic lability/instability characterized by hypoglycemia or ketoacidosis (>2 hospital admissions in the previous year), erratic glucose profiles (mage>120 mg/dl), or disruption in lifestyle of danger to life, self or others
boolean
C0020615 (UMLS CUI [1,1])
C0220982 (UMLS CUI [1,2])
C0184666 (UMLS CUI [1,3])
C0428548 (UMLS CUI [2])
C0023676 (UMLS CUI [3,1])
C2826244 (UMLS CUI [3,2])
reduced awareness of hypoglycemia, episode of severe hypoglycemia
Item
reduced awareness of hypoglycemia or >1 episode in the last 1.5 years of severe hypoglycemia
boolean
C0392756 (UMLS CUI [1,1])
C1389777 (UMLS CUI [1,2])
C0020615 (UMLS CUI [1,3])
C4013228 (UMLS CUI [2])
poor glucose control, hba1c
Item
persistently poor glucose control (as defined by hgba1c>10% at the end of six months of intensive management efforts with the diabetes care team)
boolean
C0421258 (UMLS CUI [1,1])
C0202054 (UMLS CUI [1,2])
secondary complications, proliferative retinopathy or clinically significant macular edema or therapy with photocoagulation, urinary albumin excretion rate, proteinuria, symptomatic autonomic neuropathy, postural hypotension, astroparesis or diarrhea attributed to diabetic neuropathy, or neuropathic bladder
Item
progressive secondary complications as defined by (i) a new diagnosis by an ophthalmologist of proliferative retinopathy or clinically significant macular edema or therapy with photocoagulation during the last year; or (ii) urinary albumin excretion rate >300 mg/day but proteinuria <3g/day; or (iii) symptomatic autonomic neuropathy (as defined by postural hypotension in the setting of euvolemia, gastroparesis or diarrhea attributed to diabetic neuropathy, or neuropathic bladder as diagnosed by an urologist)
boolean
C0342257 (UMLS CUI [1])
C0339467 (UMLS CUI [2,1])
C0730284 (UMLS CUI [2,2])
C0395565 (UMLS CUI [2,3])
C1318429 (UMLS CUI [3,1])
C0033687 (UMLS CUI [3,2])
C0271686 (UMLS CUI [4,1])
C2676407 (UMLS CUI [4,2])
C0267176 (UMLS CUI [4,3])
C0342288 (UMLS CUI [4,4])
C0005697 (UMLS CUI [4,5])
age
Item
4. age 18 to 65 years of age.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
immunosuppressive agents
Item
1. current use of immunosuppressive agents
boolean
C0021081 (UMLS CUI [1])
lymphopenia or leukopenia
Item
2. lymphopenia (<1000/µl) or leukopenia (<3000 total leukocytes/µl)
boolean
C0024312 (UMLS CUI [1])
C0023530 (UMLS CUI [2])
panel-reactive anti-hla antibody
Item
3. presence of panel-reactive anti-hla antibody >20%
boolean
C3508207 (UMLS CUI [1])
lymphocytotoxic cross-match
Item
4. positive lymphocytotoxic cross-match using donor lymphocytes and serum
boolean
C0549171 (UMLS CUI [1])
ebv infection, ebv serology
Item
5. evidence of acute ebv infection (igm>igg) or negative screen for ebv by igg determination
boolean
C0149678 (UMLS CUI [1,1])
C0201373 (UMLS CUI [1,2])
gfr
Item
6. calculated or measured gfr < 60 ml/min/m2
boolean
C0017654 (UMLS CUI [1])
portal hypertension, liver disease
Item
7. portal hypertension or history of significant liver disease
boolean
C0020541 (UMLS CUI [1])
C0023895 (UMLS CUI [2])
history of malignancy except for adequately treated basal or squamous cell ca of the skin
Item
8. history of malignancy within 10 years (except for adequately treated basal or squamous cell ca of the skin)
boolean
C2735088 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
active peptic ulcer disease
Item
9. active peptic ulcer disease
boolean
C0030920 (UMLS CUI [1,1])
C2707252 (UMLS CUI [1,2])
severe diarrhea, gi disorders potentially interfering with the ability to absorb oral medications
Item
10. severe unremitting diarrhea or other gi disorders potentially interfering with the ability to absorb oral medications
boolean
C1443924 (UMLS CUI [1])
C0017178 (UMLS CUI [2,1])
C0392687 (UMLS CUI [2,2])
untreated proliferative retinopathy
Item
11. untreated proliferative retinopathy
boolean
C0339467 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
pregnancy or breastfeeding
Item
12. pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
female subjects not post-menopausal or surgically sterile, or not using an acceptable method of contraception
Item
13. female subjects not post-menopausal or surgically sterile, or not using an acceptable method of contraception
boolean
C1960468 (UMLS CUI [1,1])
C0015787 (UMLS CUI [1,2])
C0232970 (UMLS CUI [1,3])
C0700589 (UMLS CUI [1,4])
active infections
Item
14. active infections
boolean
C0205177 (UMLS CUI [1,1])
C3714514 (UMLS CUI [1,2])
hiv, hep b, hep c
Item
15. serologic evidence of infection with hiv, or hbsag or hcv ab positive
boolean
C0019682 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
psychiatric illness
Item
16. major ongoing psychiatric illness
boolean
C0004936 (UMLS CUI [1])
substance use disorder, compliance
Item
17. ongoing substance abuse, drug or alcohol; or recent history of noncompliance
boolean
C0038586 (UMLS CUI [1])
C1321605 (UMLS CUI [2])
comorbidity, exclusion
Item
18. any condition that in the opinion of the principle investigator would not allow for safe participation in the study
boolean
C0009488 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial